Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Beta Pharma, Inc. logo — company profile

Beta Pharma, Inc.

Founded 1996 United States Princeton, United States 35 employees Biotechnology, Health Care +1

General Information

Company Name Beta Pharma, Inc.
Founded Year 1996
Location United States Princeton, United States +1
Employees 35
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when Beta Pharma, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Beta Pharma, Inc.

Beta Pharma, Inc. is an emerging specialty pharmaceutical company with a strong focus on oncology. Founded in 1996 at Science Park of Yale, the company started as a contract research organization providing custom synthesis services for the pharmaceutical and biotechnology R&D community. In 2006, Beta Pharma entered the clinical trial phase with its novel EGFR inhibitor, Icotinib, which was subsequently approved by the SFDA in 2011. The company's product pipeline is diverse and rapidly evolving, with global registration of Icotinib in progress through regional partners. Beta Pharma operates in the Biotechnology, Health Care, and Pharmaceutical sectors, with its headquarters based in the United States. As an investment opportunity, Beta Pharma, Inc. presents a promising potential within the specialty pharmaceutical sector, particularly in the field of oncology. The company's successful development and approval of Icotinib, along with the diverse and rapidly evolving product pipeline, make it an attractive prospect for venture capital investment. The solid foundation at Science Park of Yale and the innovative approach towards late stage therapies underlines the company's potential for long-term growth and market impact. With the right strategic investment, Beta Pharma has the opportunity to expand its market presence and make significant strides in the oncology treatment landscape.

Taxonomy: specialty pharmaceutical, oncology, drug discovery, clinical trials, EGFR inhibitor, contract research organization, custom synthesis, late stage therapies, Science Park of Yale, Icotinib, global registration, biopharmaceutical, innovation

No funding data available for Beta Pharma, Inc. yet.

Get notified when Beta Pharma, Inc. raises funding

Beta Pharma, Inc. Alternatives & Competitors

Beta Pharma, Inc. vs
Pharma in silica
Pharma in silica Canada

Clever silica nanocarriers

Undisclosed
7 employees
Health Care, Pharmaceutical
Beta Pharma, Inc. vs
Tiruvision Medicare
Tiruvision Medicare India

Third Party Pharmaceutical Manufacturer and Exporter (WHO GMP) - Tablets, Capsules, Dry & Liquid Syr...

21 employees
Manufacturing, Pharmaceutical
Beta Pharma, Inc. vs
Boston Biomedical, Inc.
Boston Biomedical, Inc. United States

Boston Biomedical, Inc. is a leading developer of novel cancer therapeutics with the goal of signifi...

Series Unknown
31 employees
Biotechnology, Health Care

FAQ About Beta Pharma, Inc.

Beta Pharma is an emerging specialty pharmaceutical company dedicated to the discovery, development and commercialization of innovative late stage therapies targeting oncology. Our products pipeline is diverse and undergoing rapid development. Beta Pharma Inc. was founded in 1996, at Science Par...
Beta Pharma, Inc. was founded in 1996.
Beta Pharma, Inc. is headquartered in Princeton, United States.
Beta Pharma, Inc. operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Beta Pharma, Inc. has approximately 35 employees.
Top alternatives and competitors to Beta Pharma, Inc. include Pharma in silica, Tiruvision Medicare, Boston Biomedical, Inc., Sciecure Pharma, SIDDHA Global. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Beta Pharma, Inc. and Pharma in silica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Beta Pharma, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy